Development of Protective Immunity in New Zealand White Rabbits Challenged with Bacillus anthracis Spores and Treated with Antibiotics and Obiltoxaximab, a Monoclonal Antibody against Protective Antigen

The recommended management of inhalational anthrax, a high-priority bioterrorist threat, includes antibiotics and antitoxins. Obiltoxaximab, a chimeric monoclonal antibody against anthrax protective antigen (PA), is licensed under the U.S. Food and Drug Administration's (FDA's) Animal Rule...

Descripción completa

Detalles Bibliográficos
Autores principales: Henning, Lisa N., Carpenter, Sarah, Stark, Gregory V., Serbina, Natalya V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2018
Materias:
Clinical Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786786/
https://www.ncbi.nlm.nih.gov/pubmed/29133571
http://dx.doi.org/10.1128/AAC.01590-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786786/
https://www.ncbi.nlm.nih.gov/pubmed/29133571
http://dx.doi.org/10.1128/AAC.01590-17

Ejemplares similares